Ab btr act. Mo 1, a phagocyte surface glycoprotein heterodimer, is involved in a number of phagocyte adhesion functions such as binding and ingestion of serum-opsonized particles, zymosan-induced degranulation, and superoxide generation. Deficiency of this antigen in humans has been associated with increased susceptibility to recurrent bacterial infections. The beta subunit of Mo I is shared by another surface glycoprotein named LFA-1, which is involved in lymphocyte proliferation, cytolytic T cell, and natural killing activities. Two unrelated patients with Mol deficiency were found to be deficient in LFA-1 as well as in the common beta subunit. Investigation of lymphocyte functions in these two patients revealed normal mixed leukocyte culturegenerated cytolytic T cell and natural killing activities and significantly reduced proliferative response to phytohemagglutinin. LFA-1-deficient cells also proliferated in response to soluble antigen and different alloantigens. These responses were partially blocked by anti-LFA-1 antibody. Whereas LFA-1 was undetectable by immunofluorescence and immunoprecipitation on the patients' resting T cells, significantly reduced (-5% of normal) but detectable amounts of the heterodimeric LFA-1 antigen were found on mitogen and alloantigen-activated T cells. On granulocytes, Mol surface expression was also dependent on the state of cellular activation. The amount of surface Mo 1 present on resting normal granulocytes increased by 3-10-fold following exposure to stimuli that induced degranulation, suggesting the presence of a major intracellular pool for this antigen. Analysis of subcellular fractions from granulocytes showed that intracellular Mol is located primarily in the specific granule fraction. Activated granulocytes had little or no increase in their surface expression of LFA-I antigen. Deficient granulocytes had significantly increased numbers of Mo 1 antigen expressed on the surface following stimulation with calcium ionophore (I MM). However, the amount expressed continued to be significantly reduced compared with normal cells. Quantitation of surface Mol on granulocytes exposed to calcium ionophore (1 AM) showed that both parents in one family but only the mother in'the other family had significantly reduced levels of Mol, suggesting heterogeneity in the inheritance of this disorder. Whereas LFA-1 deficiency on lymphocytes was associated with normal alloantigen-induced cytolytic T cell and natural killing activities in these two patients, functions which were in part dependent on small amounts of detectable LFA-I antigen, the Mo 1 deficiency state led to significant defects in phagocyte adhesion functions. Hence, the clinical symptoms associated with this combined defi-
Introduction
Adherence between cells of the immune system, such as lymphocytes, monocytes, or granulocytes, and other cells or particles is an important step in the complex series of events that mediate such biologic functions as cell-mediated killing, phagocytosis, chemotaxis, degranulation, and superoxide anion production. The use of monoclonal antibodies to cell surface structures has identified two distinct surface molecules (Mol and LFA-1) which appear to be involved in some of these adherence reactions (1) (2) (3) . Mol, a structure closely associated or identical with the human complement C3bi receptor, consists oftwo noncovalently linked glycoproteins of 155 (alpha subunit) and 94 kD (beta subunit) (1, 4, 5) . It is present on human monocytes, granulocytes, and null cells (5, 6) . LFA-1, an antigen associated with lymphocyte functions, is also a heterodimer (alpha subunit, 177 kD; beta subunit, 94 kD) and is present on T and B cells, monocytes, and granulocytes (2, 3) . Previous studies in the mouse (3, 7) and human systems (8; Borst, J., and C. Terhorst, unpublished data) demonstrated that the beta subunits of LFA-1 and Mol (or the related epitopes, Mac-i and OKM1) are highly homologous or identical. Monoclonal antibodies directed to Mol on phagocytes or LFA-1 on lymphocytes inhibit the rate of phagocytosis of opsonized particles or lymphocyte-mediated cytolysis, respectively (1, 2) , a finding that is consistent with their function as adherence molecules.
Recently, two unrelated patients with recurrent bacterial infections and Mol deficiency were described (9) (10) (11) (12) . The patients' phagocytes were deficient in both the alpha and beta subunits of Mol and had impaired phagocytosis of opsonized particles as well as defective zymosan-induced degranulation and superoxide generation. In this report, we present data showing that leukocytes from these two patients are also deficient in LFA-1. We also determined the effects of LFA-1 deficiency on lymphocyte proliferation and cytotoxic activities. The amount of LFA-1 and Mol expressed on the surface of lymphocytes and granulocytes, respectively, was critically dependent on the state of activation of these cells. Detectable but significantly reduced amounts of LFA-1 antigen with normal mobility on polyacrylamide gels were seen on activated but not resting T cells from these patients. Activated granulocytes from the parents of one patient but only the mother of the other patient expressed significantly reduced amounts of Mol, suggesting heterogeneity in the mode of inheritance of this disease.
Methods
Cell separation. Human peripheral blood leukocytes (PBL) and nonadherent cells containing predominantly T lymphocytes were isolated as detailed elsewhere (5) . Granulocytes were purified at 4°C on cushions of Ficol-Hypaque (specific gravity 1095) followed by hypotonic lysis of the contaminating erythrocytes (modified from reference 13). Monocytes were obtained by adherence of PBL to petri dishes (5), or by centrifugation of PBL on a Percoll gradient (14) . B cell lines Laz 509, 388, Namalva, and Daudi were kindly provided by Dr (19) . Immunoprecipitation from '25l-surface labeled granulocytes or PHA-generated lymphoblasts using monoclonal antibodies to LFA-I or anti-Mol were performed and analyzed exactly as described elsewhere (1).
Quantitation of cell surface Mol antigen was also done using a direct binding assay (1) . Briefly, 75 ul of granulocytes (3 X 107/ml for untreated cells, or I X 107/ml for calcium ionophore-treated cells) were incubated with increasing amounts of '25I-Fab anti-Mo 1 in the presence or absence of a 100-fold molar excess of unlabeled antibody in a total volume of 100 Ml of phosphate-buffered saline (PBS), pH 7.4, containing 0.5% human serum albumin. Incubation was done for 40 min at 0°C, after which granulocytes were separated from unbound antibody on phthalate oil cushions and the specific binding calculated (1) .
Lymphocyte proliferation and cytotoxicity assays. Proliferation and cytolytic T lymphocyte (CTL) assays were performed as previously described (modified from Reference 17 (22) . Approximately 70% of total cobalamin-binding protein was in the specific granule fraction with 15% of total present in each of the alpha and gamma fractions, respectively. The membrane (gamma) fraction contained 73% of total alkaline phosphatase activity with 17 and 10% present in the beta and alpha granule fraction, respectively. The alpha granule fraction contained 68% of the total myeloperoxidase activity, with 19% and 13% of the total present in the beta and gamma fractions, respectively (data not shown). The protein content of each fraction was measured by the method of Lowry et al. (23) using human serum albumin (Armor Pharmaceutical Co., Kankakee, IL) as standard. 50 Mg of each fraction were incubated for 10 min at 0C in PBS containing phenylmethylsulfonyl fluoride (2 mM) and 0.5% Non-idet P40 (NP40), and then radiolabeled with 125I (New England Nuclear) using the chloramine T method (24) . A sample from each fraction was removed for trichloracetic acid precipitation and the rest of the samples were extensively dialyzed against ice-cold PBS. Immunoprecipitation using anti-Mol monoclonal antibody was performed as described (1 (2, 15, 18) . Using this same antibody, no detectable radiolabeled bands were immunoprecipitated from the patient's '25I-labeled cells (Fig. 2) although '25I-labeling of surface proteins of patient's was similar to that of control cells (data not shown).
Other antigens, such as 1-2 (Ia), T3, T4, and T8, were expressed normally on the patients' circulating cells (Fig. 1 , Table I , and data not shown). Other monoclonal antibodies to LFA-1 (L5, LI 1, and TA-1) were unreactive with the patients' granulocytes and resting T cells by immunofluorescence analysis suggesting that these two patients are probably deficient in the whole LFA-1 molecule rather than in a single epitope. In a similar manner, no detectable bands were immunoprecipitated from the patients' granulocytes using monoclonal antibodies to the alpha subunit of Mol and to the common beta subunit (reference 10 and data not shown).
Alloantigen, mitogen, and antigen-induced proliferation of LFA-I-deficient lymphocytes. (9) mediated killing based on the ability of monoclonal antibodies to inhibit these functions on normal cells (2, 3, 15) . The effect of LFA-1 deficiency on these functions was next examined. As shown in Table II , LFA-l-deficient lymphocytes proliferated in response to alloantigenic stimuli produced by four different B cell lines as well as to TT antigen. Mitogen-induced lymphoproliferation was normal in response to Con A (6.25-62.5 ,gg/ml). PHA (0.125-0.25 gg/ml) induced lymphoproliferation was significantly reduced in both LFA-1-deficient patients and was more striking at the lower concentration of the lectin (Table II and data not shown). The introduction of anti-LFA-1 (LI or L5) inhibited the patient's proliferative responses to soluble antigen, lectins, and alloantigens by 20-60% ( Table   Table I 4 Numbers indicate relative specific fluorescence intensity (linear scale) computed from the peak linear fluorescence channels for cells stained with each monoclonal reagent minus the peak channels of cells stained with a nonreactive control antibody. For each antigen, the fluorescence intensity of the control individual's cells has been arbitrarily assigned 100 units.
II), suggesting a partial dependence of these responses on LFA-I antigen, despite deficient cellular expression.
Cytolytic T cell activity of LFA-i-deficient lymphocytes. LFA-1-deficient effector cells generated in MLR demonstrated normal CTL-mediated killing activity over a wide range of effector-to-target cell ratios (Fig. 3) . Again, incubation of MLRgenerated blasts with anti-LFA-1 blocked allogeneic CTL activity by 80-90% (Fig. 3) .
Detection of surface LFA-1 on PHA-or MLR-generated lymphoblasts from LFA-1 deficiency patients. The fact that lymphocytes from these patients were able to generate proliferative and cytotoxic responses that were partially blocked by anti-LFA-1 antibody, despite the absence of detectable quantities of LFA-1 on the surface of resting T cells, was an enigma. Since these responses were mediated by "activated" T cells, we examined the possibility that LFA-1 antigen may be expressed on the surface of deficient cells by mitogenic or alloantigenic stimuli. We found that PHA-or MLR-generated lymphoblasts from normal individuals increased their surface expression of LFA-1 by six-eightfold compared with unstimulated cells as determined by indirect immunofluorescence analysis (Fig. 4 A) . Whereas the patients' resting lymphocytes had no detectable levels of LFA-1, their PHA-or MLRgenerated blasts had detectable amounts of both the alpha and beta subunits of LFA-1 that had normal mobility on polyacrylamide gel electrophoresis (Fig. 4 A and B) . Patients' cells, however, continued to be markedly deficient (-5% of normal) in surface LFA-1 compared with controls (Fig. 4) . 8 ), representing about a sevenfold increase over the levels measured on unstimulated cells (10) . This number was still significantly less than that expressed on calcium ionophorestimulated normal cells (Fig. 8) . Of special interest was the finding that calcium ionophore treatment of granulocytes from the parents of the two patients led to the detection of a carrier Effect of degranulation on surface expression of Mol in normal granulocytes. The degree of surface expression of Mo 1 on normal granulocytes was also crucially dependent on the state of activation of these cells. Stimuli that induced degranulation, such as calcium ionophore, PMA, C5a, and f-MetLeu-Phe, increased surface expression of Mo 1 on normal granulocytes by 3-10-fold (Fig. 5 ). This increase in Mol surface expression was temperature-dependent ( Fig. 5) and irreversible up to I h at 37°C (data not shown). Phagocytosis by granulocytes of C3 and/or IgG-opsonized particles also produced a significant increase in surface Mol expression (Fig.  5) . Both the alpha and beta subunits of Mol in granulocytes were present predominantly in the specific granule fraction in state which was not apparent by immunofluorescence analysis of the unstimulated cells (Table III) . Direct binding assays on calcium ionophore-treated cells (Fig. 8) showed that the parents of patient one (9) but only the mother of patient two (11) were possible heterozygotes for Mol deficiency.
Discussion
Mol deficiency is a phagocyte disorder that presents clinically with recurrent bacterial infections and is associated in vitro with defective granulocyte adhesion functions (1, (9) (10) (11) . In this report, we found that leukocytes from two unrelated patients with Mol deficiency were also markedly deficient in LFA-1, another leukocyte surface glycoprotein that shares a common beta subunit with Mol. On normal leukocytes, the surface expression of Mo 1 and LFA-1 is regulated by the state of activation of the effector cell. On resting peripheral blood T cells, only a small amount of LFA-1 is expressed on the plasma membrane (Fig. 4 A) . Upon mitogenic or alloantigenic stimulation, a marked increase in LFA-1 surface antigen is detected by immunofluorescence analysis (Fig. 4 A) , in agreement with the observation made on human cytolytic T cell lines (2) . In normal unstimulated granulocytes, a major portion of Mol is located intracellularly in the specific granule fraction (Fig. 6) . Recently, gelatinase-containing (cobalamin-binding protein free) granules with the same density as the specific granules were described (25) . Whether some of the Mol antigen is also present in this novel granule remains to be established. Stimuli that led to degranulation such as calcium inophore A23187, chemotactic peptides (f-Met-Leu-Phe or C5a), PMA, or phagocytosis produced a 3-to 10-fold increase in Mol surface expression. There was no comparable increase in LFA-1 surface expression although both Mol and LFA-1 may share the same beta subunit (8) . Translocation of the Mol heterodimer from the specific granule fraction to the plasma membrane probably mediates the increase in Mol surface expression on granulocytes. The mechanism leading to an increase in surface LFA-1 on lymphocytes is unclear but may involve neosynthesis. In addition to Mol, three other granulocyte antigens, the C3b receptor, f-Met-Leu-Phe receptor, and cytochrome b significantly increase on the surface upon stimulation (21, 26, 27) . These findings suggest a common mechanism whereby granulocytes store a large proportion of functionally active molecules intracellularly and translocate them to the plasma membrane upon activation.
LFA-1-deficient resting T cells proliferated in response to a variety of stimuli such as antigen, mitogen, and alloantigens (Table II) . They also had normal T cell-mediated cytolysis of two different B cell targets and natural killing of K562 target cells (Fig. 3) (10) . The partial or more complete inhibition by LFA-1 monoclonal antibodies in both patient and control cells suggested the involvement of LFA-1 antigen in these responses (Table II and Fig. 3 ). Whereas no detectable LFA-1 was seen on granulocytes or resting T cells (Figs. 1 and 2 , Table I) , PHA-or MLR-activated lymphoblasts from these patients expressed detectable amounts of LFA-1 on the cell surface (Fig. 4 A) fate-polyacrylamide gel electrophoresis analysis (Fig. 4 B) . The amount of LFA-1 that was expressed on the surface of PHAor MLR-generated lymphoblasts continued to be markedly reduced (-5% of normal) compared with normal cells (Fig. 4  A) . The abnormally low lymphoproliferative response to PHA shown by these two patients may be a manifestation of this degree of LFA-1 deficiency (Table II) . This abnormality was more apparent at lower concentrations of the mitogen (Table  II) (primary granules), beta (specific granules), or gamma (plasma membrane). In addition to Mol, two unidentified bands of apparent molecular weights 185 and 78 kD were seen only in the beta fraction. Mol was primarily detected in the plasma membrane and specific granule fractions but not in the primary granules.
third patient with recurrent bacterial infections (28 bacterial infections in these two patients with this combined immunodeficiency disorder. Quantitation of Mol expressed on the surface of calcium ionophore A23 187-treated cells from the parents of these two patients showed that granulocytes from the parents of one patient but only the mother of the other patient had significantly reduced numbers (~-50%) of Mol binding sites compared with normal cells (Fig. 8) . This finding may suggest (a) an inability of these granulocytes to fully express their normal content of Mol upon optimal activation, or (b) that these cells have -50% of the normal total cellular content of this antigen. Previous studies (9, 11) showed that granulocytes from these patients had a normal secretory response suggesting that the differences noted in Mo 1 surface expression are not a reflection of a degranulation defect. In favor of the second possibility is previous data showing that these same individuals had -50% of the normal total granulocyte content of "gp 150" as determined by densitometric scanning of the total cell lysate (9, 1 1). Therefore, these studies suggest a heterogeneity in the inheritance of Mol deficiency in humans. They also point out the importance of standardizing the state of activation of effector cells in future studies aimed towards phenotyping relatives of these patients and understanding the molecular basis of this newly recognized disorder. * Numbers indicate relative specific fluorescence intensity (linear scale) computed from the peak linear fluorescence channels for cells stained with each monoclonal reagent minus the peak channels of cells stained with a nonreactive control antibody. For each antigen, the fluorescence intensity of the control individual's cells has been arbitrarily assigned 100 units.
